![]()
|
Report Date : |
15.01.2008 |
IDENTIFICATION
DETAILS
|
Name : |
Advance Animal Science Co Ltd |
|
|
|
|
Registered Office : |
Khalil Mansion, 149/4, DIT Extension Road, Motijheel Commercial
Area, Dhaka-1000 |
|
|
|
|
Country : |
Bangladesh |
|
|
|
|
Date of Incorporation : |
4th October, 1999 |
|
|
|
|
Com. Reg. No.: |
C-38745 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Engaged in importing and selling of Veterinary Medicines. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Advance Animal Science Co Ltd
Khalil
Mansion,
149/4, DIT Extension Road,
Motijheel Commercial Area,
Dhaka-1000,
Bangladesh
Telephones : 880-2-8322377, 8158965,
8158967-8,
Fax : 880-2-7135395,
8112183,
E-mail : advance@bdmail.net
House
No.2/10,
Block-B,
Lalmatia,
Dhaka,
Established :
October, 1999
Incorporation
No. :
C-38745
Incorporation
Dated : 4th
October, 1999
Managing
Director & CEO :
Mr. M. M. Khan
20
Executives- 2
Junior
Executives- 3
Field
Staffs- 8
General
Staffs- 7
National Bank
Limited
Dilkusha
Branch,
Dhaka
Pubali Bank
Limited
Motijheel
Commercial Area,
Dhaka
N/A
NIL
800 sq. ft. (rented)
N/A
1,500 sq.
ft. (rented)
Mr. M. M.
Khan - Chairman & Managing Director
Mrs. Mamuna
Khan
Subject was established in October, 1999 by Mr. M. M. Khan
and the other director in Dhaka city.
The company is engaged in importing and selling of Veterinary
Medicines.
Veterinary Medicines
Injections
Vaccinations
Production
Capacity------------ N/A
Last year
Production------------N/A
Germany
USA
Netherlands
NIL
NIL
Dhaka
Chamber of Commerce & Industries, Dhaka.
Subject is a Private Limited company incorporated with the
Registrar of Joint Stock of Companies Dhaka.
2006 2005 2004
Capital Invested Tk.20
million Tk.23 million Tk.23 million
Turnover Tk.180
million Tk.180 million Tk.178 million
Liability Tk.2
million Tk.2.7 million Tk.3 million
Fixed Assets Tk.22
million Tk.22 million Tk.22 million
Authorized Capital Tk.10 million
Paid Up Capital Tk.100, 000.00
Each Share value Tk.100.00
GB Pound 1.00=Tk. 143.7238
US Dollar 1.00=Tk. 69.4023
Europe
Euro 1.00=Tk.101.3730
Japanese Yen 1.00=Tk. 0.6176
Australian
Dollar 1.00=Tk. 63.2055
Subject is a private limited company engaged in importing
and selling of veterinary medicines, injections and vaccinations to local
market.
Directors are experienced businessman of good reputation.
They are financially and good their business commitments, it reported.
The company is good for normal business engagements.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)